<code id='30B86CB88B'></code><style id='30B86CB88B'></style>
    • <acronym id='30B86CB88B'></acronym>
      <center id='30B86CB88B'><center id='30B86CB88B'><tfoot id='30B86CB88B'></tfoot></center><abbr id='30B86CB88B'><dir id='30B86CB88B'><tfoot id='30B86CB88B'></tfoot><noframes id='30B86CB88B'>

    • <optgroup id='30B86CB88B'><strike id='30B86CB88B'><sup id='30B86CB88B'></sup></strike><code id='30B86CB88B'></code></optgroup>
        1. <b id='30B86CB88B'><label id='30B86CB88B'><select id='30B86CB88B'><dt id='30B86CB88B'><span id='30B86CB88B'></span></dt></select></label></b><u id='30B86CB88B'></u>
          <i id='30B86CB88B'><strike id='30B86CB88B'><tt id='30B86CB88B'><pre id='30B86CB88B'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:fashion    Page View:727
          Rep. Larry Bucshon (R-Ind.) received a significant amount of campaign donations from the pharmaceutical industry in the second quarter of 2023. House Television via AP

          WASHINGTON — The pharmaceutical industry has been flooding the campaign coffers of Rep. Larry Bucshon, a cardiothoracic surgeon and Republican from Indiana, according to a STAT analysis of this quarter’s filings.

          CEOs of pharmaceutical giants, executives of the brand-drug lobby PhRMA, and companies’ political action committees all gave in higher-than-usual numbers to the rank-and-file House member last quarter. The total was nearly $56,000 between April 14 and June 30.

          advertisement

          Bucshon is a member of the House Energy & Commerce Committee, which works on drug pricing issues, and the GOP Doctors Caucus, but he doesn’t hold leadership positions in either.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more
          An inside look at PIPEs, biotech's buzzy new financing tool
          An inside look at PIPEs, biotech's buzzy new financing tool

          MollyFerguson/STATBiotechisawashinPIPEs.Thenumbersbehindtheseprivatelynegotiatedpurchasesofpublic-co

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          How to address the problem of discarded donor organs

          Adoctorflushesadonorkidneyduringatransplantprocedure.BRENDANSMIALOWSKI/AFP/GettyImagesAsIwasgettingr